Case Study: a Japanese pharmaceutical and biotechnology company accelerates global regulatory submissions with FREYR

Japanese Pharmaceutical and Biotechnology Company reduces manual efforts by 50% with FREYR

The customer, a Japanese pharmaceutical and biotechnology company, faced challenges in meeting health authority quality compliance for its published reports and lacked sufficient local expertise for its European submissions. To accelerate its regulatory operations across global markets, it partnered with FREYR for comprehensive support, including Regulatory Operations, Publishing Services, and Clinical Trial Support (CTS).

FREYR implemented a solution that provided global regulatory support as an "extended arm" to the client, including SOP development, publishing tool testing, and data migration. This intervention resulted in a 50% reduction in manual efforts and ensured high-quality submissions compliant with health authority standards. FREYR's support also enabled the client's successful global resource expansion into new markets, leading to faster market entry and enhanced operational efficiency.